Review of injectable cartilage engineering using fibrin gel in mice and swine models

Giuseppe M. Peretti, Jian Wei Xu, Lawrence J. Bonassar, Carl Hendrick Kirchhoff, Michael J. Yaremchuk, Mark A. Randolph

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

More than a decade of work has been devoted to engineering cartilage for articular surface repair. This review covers the use of fibrin gel polymer as an injectable scaffold for generating new cartilage matrix from isolated articular chondrocytes beginning with studies in mice and culminating in an applied study in swine joints. These studies began with developing a formulation of fibrin that was injectable and promoted cartilage matrix formation. Subsequent studies addressed the problems of volume loss after the scaffolds were placed in vivo by adding lyophilized cartilage matrix. Additional studies focused on the ability of isolated chondrocytes to heal and repair cartilage in a model that could be biomechanically tested. In conclusion, this series of studies demonstrated that fibrin gel is a suitable polymer gel for generating new cartilage matrix from articular chondrocytes. The new matrix is capable of forming mechanical bonds between cartilage disks and can lead to healing and integration. Armed with these results, implantation of fibrin-cell constructs into defects in swine knees showed new cartilage formation and filling of the defects. Continuing work in these models with fibrin and other polymerizable hydrogels could result in a suitable cell-based therapy for articular cartilage lesions.

Original languageEnglish
Pages (from-to)1151-1168
Number of pages18
JournalTissue Engineering
Volume12
Issue number5
DOIs
Publication statusPublished - May 2006

Fingerprint

Cartilage
Fibrin
Swine
Gels
Injections
Articular Cartilage
Chondrocytes
Polymers
Joints
Scaffolds
Hydrogels
Repair
Cell- and Tissue-Based Therapy
Knee
Defects

ASJC Scopus subject areas

  • Biophysics
  • Cell Biology
  • Biotechnology

Cite this

Peretti, G. M., Xu, J. W., Bonassar, L. J., Kirchhoff, C. H., Yaremchuk, M. J., & Randolph, M. A. (2006). Review of injectable cartilage engineering using fibrin gel in mice and swine models. Tissue Engineering, 12(5), 1151-1168. https://doi.org/10.1089/ten.2006.12.1151

Review of injectable cartilage engineering using fibrin gel in mice and swine models. / Peretti, Giuseppe M.; Xu, Jian Wei; Bonassar, Lawrence J.; Kirchhoff, Carl Hendrick; Yaremchuk, Michael J.; Randolph, Mark A.

In: Tissue Engineering, Vol. 12, No. 5, 05.2006, p. 1151-1168.

Research output: Contribution to journalArticle

Peretti, GM, Xu, JW, Bonassar, LJ, Kirchhoff, CH, Yaremchuk, MJ & Randolph, MA 2006, 'Review of injectable cartilage engineering using fibrin gel in mice and swine models', Tissue Engineering, vol. 12, no. 5, pp. 1151-1168. https://doi.org/10.1089/ten.2006.12.1151
Peretti, Giuseppe M. ; Xu, Jian Wei ; Bonassar, Lawrence J. ; Kirchhoff, Carl Hendrick ; Yaremchuk, Michael J. ; Randolph, Mark A. / Review of injectable cartilage engineering using fibrin gel in mice and swine models. In: Tissue Engineering. 2006 ; Vol. 12, No. 5. pp. 1151-1168.
@article{764bbeaf4fbd4a7b972fb63b7bd7f6f4,
title = "Review of injectable cartilage engineering using fibrin gel in mice and swine models",
abstract = "More than a decade of work has been devoted to engineering cartilage for articular surface repair. This review covers the use of fibrin gel polymer as an injectable scaffold for generating new cartilage matrix from isolated articular chondrocytes beginning with studies in mice and culminating in an applied study in swine joints. These studies began with developing a formulation of fibrin that was injectable and promoted cartilage matrix formation. Subsequent studies addressed the problems of volume loss after the scaffolds were placed in vivo by adding lyophilized cartilage matrix. Additional studies focused on the ability of isolated chondrocytes to heal and repair cartilage in a model that could be biomechanically tested. In conclusion, this series of studies demonstrated that fibrin gel is a suitable polymer gel for generating new cartilage matrix from articular chondrocytes. The new matrix is capable of forming mechanical bonds between cartilage disks and can lead to healing and integration. Armed with these results, implantation of fibrin-cell constructs into defects in swine knees showed new cartilage formation and filling of the defects. Continuing work in these models with fibrin and other polymerizable hydrogels could result in a suitable cell-based therapy for articular cartilage lesions.",
author = "Peretti, {Giuseppe M.} and Xu, {Jian Wei} and Bonassar, {Lawrence J.} and Kirchhoff, {Carl Hendrick} and Yaremchuk, {Michael J.} and Randolph, {Mark A.}",
year = "2006",
month = "5",
doi = "10.1089/ten.2006.12.1151",
language = "English",
volume = "12",
pages = "1151--1168",
journal = "Tissue Engineering",
issn = "1076-3279",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Review of injectable cartilage engineering using fibrin gel in mice and swine models

AU - Peretti, Giuseppe M.

AU - Xu, Jian Wei

AU - Bonassar, Lawrence J.

AU - Kirchhoff, Carl Hendrick

AU - Yaremchuk, Michael J.

AU - Randolph, Mark A.

PY - 2006/5

Y1 - 2006/5

N2 - More than a decade of work has been devoted to engineering cartilage for articular surface repair. This review covers the use of fibrin gel polymer as an injectable scaffold for generating new cartilage matrix from isolated articular chondrocytes beginning with studies in mice and culminating in an applied study in swine joints. These studies began with developing a formulation of fibrin that was injectable and promoted cartilage matrix formation. Subsequent studies addressed the problems of volume loss after the scaffolds were placed in vivo by adding lyophilized cartilage matrix. Additional studies focused on the ability of isolated chondrocytes to heal and repair cartilage in a model that could be biomechanically tested. In conclusion, this series of studies demonstrated that fibrin gel is a suitable polymer gel for generating new cartilage matrix from articular chondrocytes. The new matrix is capable of forming mechanical bonds between cartilage disks and can lead to healing and integration. Armed with these results, implantation of fibrin-cell constructs into defects in swine knees showed new cartilage formation and filling of the defects. Continuing work in these models with fibrin and other polymerizable hydrogels could result in a suitable cell-based therapy for articular cartilage lesions.

AB - More than a decade of work has been devoted to engineering cartilage for articular surface repair. This review covers the use of fibrin gel polymer as an injectable scaffold for generating new cartilage matrix from isolated articular chondrocytes beginning with studies in mice and culminating in an applied study in swine joints. These studies began with developing a formulation of fibrin that was injectable and promoted cartilage matrix formation. Subsequent studies addressed the problems of volume loss after the scaffolds were placed in vivo by adding lyophilized cartilage matrix. Additional studies focused on the ability of isolated chondrocytes to heal and repair cartilage in a model that could be biomechanically tested. In conclusion, this series of studies demonstrated that fibrin gel is a suitable polymer gel for generating new cartilage matrix from articular chondrocytes. The new matrix is capable of forming mechanical bonds between cartilage disks and can lead to healing and integration. Armed with these results, implantation of fibrin-cell constructs into defects in swine knees showed new cartilage formation and filling of the defects. Continuing work in these models with fibrin and other polymerizable hydrogels could result in a suitable cell-based therapy for articular cartilage lesions.

UR - http://www.scopus.com/inward/record.url?scp=33745798853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745798853&partnerID=8YFLogxK

U2 - 10.1089/ten.2006.12.1151

DO - 10.1089/ten.2006.12.1151

M3 - Article

VL - 12

SP - 1151

EP - 1168

JO - Tissue Engineering

JF - Tissue Engineering

SN - 1076-3279

IS - 5

ER -